................Study after study keeps coming to the same conclusion: Flu vaccines DO NOT WORK, and in many cases do more harm than good.
In fact, before the CDC advocated vaccinating children under the age of five, the number of children dying from the flu was very low, and on the decline. Then, in 2003, just after children aged five and under started getting vaccinated, the number of flu deaths skyrocketed.
For this year’s flu season, five biopharmaceutical companies have been awarded massive contracts by the U.S. Department of Health and Human Services (HHS) for development and production of more than 195 million doses of swine flu vaccine, in addition to the seasonal flu vaccine.
The companies -- Novartis, GlaxoSmithKline, MedImmune, Australian drug maker CSL, and Sanofi-Pasteur -- will likely make a great deal of money.
CSL has contracts to supply $180 million worth of bulk antigen to the U.S. MedImmune will supply 40 million doses of its live attenuated nasal spray swine flu vaccine for more than $450 million. And Sanofi-Pasteur is providing more than 100 million doses of monovalent swine flu vaccine, a $690 million order.
More Here
In fact, before the CDC advocated vaccinating children under the age of five, the number of children dying from the flu was very low, and on the decline. Then, in 2003, just after children aged five and under started getting vaccinated, the number of flu deaths skyrocketed.
For this year’s flu season, five biopharmaceutical companies have been awarded massive contracts by the U.S. Department of Health and Human Services (HHS) for development and production of more than 195 million doses of swine flu vaccine, in addition to the seasonal flu vaccine.
The companies -- Novartis, GlaxoSmithKline, MedImmune, Australian drug maker CSL, and Sanofi-Pasteur -- will likely make a great deal of money.
CSL has contracts to supply $180 million worth of bulk antigen to the U.S. MedImmune will supply 40 million doses of its live attenuated nasal spray swine flu vaccine for more than $450 million. And Sanofi-Pasteur is providing more than 100 million doses of monovalent swine flu vaccine, a $690 million order.
More Here